Hyperoxia therapy of pre-proliferative ischemic retinopathy in a mouse model - Wikidata - wikimedia - TriplyDB

Hyperoxia therapy of pre-proliferative ischemic retinopathy in a mouse model

Hyperoxia therapy of pre-proliferative ischemic retinopathy in a mouse model

http://www.wikidata.org/entity/Q35221114

about

Endothelial tip cells in ocular angiogenesis: potential target for anti-angiogenesis therapy Hyperoxia causes regression of vitreous neovascularization by downregulating VEGF/VEGFR2 pathway.TMP prevents retinal neovascularization and imparts neuroprotection in an oxygen-induced retinopathy model.Hydrogen Sulfide Contributes to Retinal Neovascularization in Ischemia-Induced Retinopathy.TWEAK/Fn14 pathway is a novel mediator of retinal neovascularization.Higher prolactin and vasoinhibin serum levels associated with incidence and progression of retinopathy of prematurity.BH4-Mediated Enhancement of Endothelial Nitric Oxide Synthase Activity Reduces Hyperoxia-Induced Endothelial Damage and Preserves Vascular Integrity in the Neonate.Diacylglycerol kinase (DGK) inhibitor II (R59949) could suppress retinal neovascularization and protect retinal astrocytes in an oxygen-induced retinopathy model.The progress of prophylactic treatment in retinopathy of prematurity.

P2860

Q26865091-5B535B98-A7F6-4FFC-B74B-16E53A30B545 Q34544365-275644C9-2AF1-4C68-BAAD-2055C3DC7515 Q36232684-708E10E1-6B91-4591-ABD8-54B2FE0C95A6 Q36997322-6102B4F7-4F9F-4E22-9BE7-D651616DE117 Q37577284-B140AA88-D70D-4525-9573-AC6EF0EA4933 Q50122404-359913CE-C7A1-4D3D-B050-0CEA99340C1B Q50210015-60398BB0-FDDA-4062-9BF8-97AA6809A3C3 Q54305745-F071A9C9-C050-448C-AFBB-2AB3D598F988 Q54999086-210FEF2C-4A0E-46D2-ADA3-A8FDC29831B9

P2860

Hyperoxia therapy of pre-proliferative ischemic retinopathy in a mouse model

http://www.wikidata.org/entity/Q35221114

description

2011 nî lūn-bûn

@nan

2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Hyperoxia therapy of pre-proliferative ischemic retinopathy in a mouse model

@ast

Hyperoxia therapy of pre-proliferative ischemic retinopathy in a mouse model

@en

type

label

Hyperoxia therapy of pre-proliferative ischemic retinopathy in a mouse model

@ast

Hyperoxia therapy of pre-proliferative ischemic retinopathy in a mouse model

@en

prefLabel

Hyperoxia therapy of pre-proliferative ischemic retinopathy in a mouse model

@ast

Hyperoxia therapy of pre-proliferative ischemic retinopathy in a mouse model

@en

P1433

Q35221114-5EB8C785-193A-4873-9217-58972FF3D91C

P1476

Q35221114-9509DAF5-2600-4EF0-94AF-7A998FB51DFF

P2093

Q35221114-14B3E904-4866-4299-B646-7230392D1E13

Q35221114-57B53642-C0D4-48E3-8E1E-FE13FDF9BFCE

Q35221114-6E6D7C8E-0C91-4067-AF5C-33C0C09102B4

Q35221114-7F47D2C5-7693-4626-9F5C-4C9BD590F993

Q35221114-8256B225-A256-4584-810F-FCD096AE8DF8

Q35221114-899A5A51-9B1D-449D-8198-6E5C1E222E4F

Q35221114-BF6A70C2-E8E0-455F-A541-3FEEADEBB098

Q35221114-C50BBC77-9D37-47D0-8FC3-55E464C1D5C8

Q35221114-F0744E5B-87CB-4079-A537-5FF1B29A0E4C

P2860

Q35221114-0528EF0F-983F-45DE-9B86-F34AEEC8BABA

Q35221114-133063EE-34C1-4EEC-B7D2-B20C6ECB40F8

Q35221114-14F1C3A8-7D5E-4512-835D-C8D486363F41

Q35221114-1514386F-B05E-40D8-B353-793AB4FE2D09

Q35221114-1667FB1B-883D-4518-93D9-AB266EF84139

Q35221114-17B0D7E3-9587-49DB-B5D0-4A4A46F499F9

Q35221114-1BF32869-EEA4-4851-B9A1-D20CB33D0864

Q35221114-209B4D8D-7E23-493B-9169-C682E441FD6A

Q35221114-2F84793E-5FC4-4F20-92C7-6D49ECA50D5E

Q35221114-333FE61D-3610-4C04-9B09-51274990A4CD

P304

Q35221114-5B94D231-6D3D-4310-9031-45C7087F359D

P31

Q35221114-5E42D3F2-BB37-4FE8-A7CE-56A0D816FAA0

P356

Q35221114-08D9E3A6-60A3-45E3-ADAC-D03075580D90

P407

Q35221114-D60C6894-764D-40BA-A3E4-A245C98FEB66

P433

Q35221114-8D71CB0E-23E2-4C06-9935-90B0CD2CAB90

P478

Q35221114-E9ED6838-2A17-46B7-BD1A-1F5FB480B1FB

P50

Q35221114-04EAED8A-9E01-481F-ADF1-779CF2A0AA21

P577

Q35221114-F7629EEA-D56D-42B7-B6B5-E71DB6B4841A

P5875

Q35221114-0AE5ED97-02F8-47F0-A082-0665DB0B674B

P698

Q35221114-DB7DC532-0F18-4BE3-A9E8-F262F18EC9AE

P932

Q35221114-AB5C2C5D-B70F-48C1-8143-CB28D3E4B02B

P356

P1433

Investigative Ophthalmology & Visual Science

P1476

Hyperoxia therapy of pre-proliferative ischemic retinopathy in a mouse model

@en

P2093

Akitoshi Yoshida

http://www.w3.org/2001/XMLSchema#string

Dennis M Marcus

http://www.w3.org/2001/XMLSchema#string

Harumasa Yokota

http://www.w3.org/2001/XMLSchema#string

Lauren Yancey

http://www.w3.org/2001/XMLSchema#string

Robert W Caldwell

http://www.w3.org/2001/XMLSchema#string

Ruth B Caldwell

http://www.w3.org/2001/XMLSchema#string

Steven E Brooks

http://www.w3.org/2001/XMLSchema#string

Wenbo Zhang

http://www.w3.org/2001/XMLSchema#string

Zhimin Xu

http://www.w3.org/2001/XMLSchema#string

P2860

Supplemental oxygen for the treatment of prethreshold retinopathy of prematurity

Myeloid progenitors differentiate into microglia and promote vascular repair in a model of ischemic retinopathy

Clinical case report: treatment of a central retinal vein occlusion with hyperbaric oxygen

Inducible nitric oxide synthase mediates the change from retinal to vitreal neovascularization in ischemic retinopathy

Hyperbaric oxygen attenuates apoptosis and decreases inflammation in an ischemic wound model

Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury.

T2-TrpRS inhibits preretinal neovascularization and enhances physiological vascular regrowth in OIR as assessed by a new method of quantification

VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia

Computer-aided quantification of retinal neovascularization.

Insulin-like growth factor binding protein-3 mediates vascular repair by enhancing nitric oxide generation.

P304

6384-6395

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1167/IOVS.11-7666

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

52

http://www.w3.org/2001/XMLSchema#string

P50

Priya Narayanan

P577

2011-08-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51250294

http://www.w3.org/2001/XMLSchema#string

P698

21705685

http://www.w3.org/2001/XMLSchema#string

P932

3175995

http://www.w3.org/2001/XMLSchema#string